Risk of second primary malignancies (SPM) following radioactive I-131 (RAI) therapy in patients with differentiated thyroid cancer (DTC)

被引：0
作者：
Ansari, Aiysha [1 ]
Kulkarni, Kanchan [1 ]
Van Nostrand, Douglas [1 ]
Khorjekarand, Gauri [1 ]
Garcia, Carlos [1 ]
机构：
[1] WHC, Nucl Med, Washington, DC USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2010年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1084
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies
    Nguyen, Nghi C.
    Anigati, Elena M.
    Desai, Neil B.
    Oz, Orhan K.
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (04) : 488 - 496
  • [32] The first experience with Bexarotene in patients with I-131 negative differentiated thyroid cancer
    Stokkel, M. P. M.
    Smit, J. W.
    Verkooijen, R. B. T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S111 - S111
  • [33] I-131 uptake augmentation by thiazide diuretics in differentiated thyroid cancer patients
    Sayman, HB
    Senmevsim, O
    Kanmaz, B
    Mete, C
    Sager, S
    Onsel, C
    Sonmezoglu, K
    Kabasakal, L
    Uslu, I
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S466 - S466
  • [34] I-131 therapy in differentiated thyroid carcinoma patients with high thyroglobulin levels despite negative diagnostic I-131 scans
    Akgun, A.
    Yazici, B.
    Erdim, O.
    Ozcan, Z.
    Ozkilic, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S330 - S330
  • [35] DIFFERENTIATED THYROID CANCER FOLLOWING RADIOIODIDE I-131 THERAPY OF HYPER-THYROIDISM - CASE-REPORT
    NEMEC, J
    SOUMAR, J
    ZEMAN, V
    NAHODIL, V
    ZAMRAZIL, V
    SMEJKAL, V
    ONCOLOGY, 1978, 35 (06) : 277 - 280
  • [36] Effect of Depression and Anxiety on Symptoms in Thyroid Cancer Patients Undergoing Radioactive Iodine (I-131) Therapy
    Chun, Nami
    ASIAN ONCOLOGY NURSING, 2012, 12 (04) : 297 - 304
  • [37] RADIOACTIVE IODINE (I-131) IN THE POSTOPERATIVE TREATMENT OF THYROID CANCER
    BLAHD, WH
    NORDYKE, RA
    BAUER, FK
    CANCER, 1960, 13 (04) : 745 - 756
  • [38] Prevalence of Hyponatremia in Hypothyroid Patients during Radioactive I-131 Ablation for Differentiated Thyroid Cancer: Single Institution Experience
    Dayrit, Juan Carlo P.
    Cunanan, Elaine C.
    Kho, Sjoberg A.
    ENDOCRINOLOGY AND METABOLISM, 2016, 31 (03) : 410 - 415
  • [39] I-131 therapy in differentiated thyroid cancer (DTC) using recombinant human thyroid stimulating hormone (rhTSH): Biokinetic data and proposed dosing scheme
    Umlauf, Jon
    Leblond, Antoine
    Hartnett, Shelley
    Mankoff, David
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [40] Efficacy of Low-Dose I-131 Therapy for the Postoperative Ablation of Low-Risk Differentiated Thyroid Cancer Patients
    Caglar, M.
    Bozkurt, F.
    Kapulu, C.
    Ugur, O.
    Bayraktar, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S344 - S344
12345